Could cause temporary or reversible harm; serious harm is unlikely.
Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2ml vial.
| Brand name | SODIUM CHLORIDE |
| Generic name | SODIUM CHLORIDE |
| Active ingredient(s) | SODIUM CHLORIDE |
| Distributed by / for | Hikma Pharmaceuticals USA Inc. |
| NDC | 0641-0497-17 |
| Full product label | Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, Vial NDC 0641-0497-17 |
| Recalling firm | Hikma Pharmaceuticals USA Inc. |
| Distribution | Distributed Nationwide in the USA |
| Quantity | 1,324,072 vials |
| Recall initiated | 2020-12-07 |
| Report date | 2020-12-23 |
| Recall completed | 2023-07-18 |
| Recall number | D-0169-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Cherry Hill NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗